Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

357

HTML

2054

Tables (1-5)

197

Sum=2608

Mar 28, 2005 (publication date) through Jan 4, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854

Table 2 Biochemical and hematological parameters during IFNα2b with RBV therapy in chronic hepatitis C.

Time of the treatment	Alanine aminotran-sferase (U/L)	Prothrombin index (%)	Platelets (1×10³/mL)	Erythrocytes(1×10⁶/mL)	Leukocytes(1×10³/mL)
0	106±50	95±9.6	208±34	4.6±0.5	6.3±2.1
16 wk	24.4±16.7	97±6.4	198±46	4.0±0.5	5.1±2.3
32 wk	19.6±13.2	99±9.2	202±63	3.9±0.6	4.6±1.5
48 wk	35±67	100±7.4	193±62	4.1±0.6	4.9±1.9

Citation: Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1854.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1854